| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Klaus Früh | |
| Colin Powers | |||
| P2860 | cites work | Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10 | Q24540441 |
| Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11. | Q33755053 | ||
| Complete DNA sequence of the rat cytomegalovirus genome | Q33810063 | ||
| Recent advances in the therapy and prevention of CMV infections | Q33841597 | ||
| Human cytomegalovirus latency and reactivation - a delicate balance between the virus and its host's immune system | Q33854329 | ||
| Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication | Q34021267 | ||
| Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patients. | Q34294829 | ||
| Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses | Q34308375 | ||
| Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: pathogenesis | Q34343874 | ||
| A recombinant rhesus cytomegalovirus expressing enhanced green fluorescent protein retains the wild-type phenotype and pathogenicity in fetal macaques | Q34345031 | ||
| Do pathogens accelerate atherosclerosis? | Q34389205 | ||
| Mouse models of cytomegalovirus latency: overview | Q34934459 | ||
| Cloning of the Full-Length Rhesus Cytomegalovirus Genome as an Infectious and Self-Excisable Bacterial Artificial Chromosome for Analysis of Viral Pathogenesis | Q34975353 | ||
| Direct Relationship between Suppression of Virus-Specific Immunity and Emergence of Cytomegalovirus Disease in Simian AIDS | Q34977168 | ||
| Complete sequence and genomic analysis of rhesus cytomegalovirus | Q35020562 | ||
| Rhesus cytomegalovirus is similar to human cytomegalovirus in susceptibility to benzimidazole nucleosides | Q35124909 | ||
| CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation | Q35139332 | ||
| Disseminated cytomegalovirus infection in immunodeficient rhesus monkeys | Q35856293 | ||
| Temple monkeys and health implications of commensalism, Kathmandu, Nepal | Q36026231 | ||
| Flow cytometric detection of degranulation reveals phenotypic heterogeneity of degranulating CMV-specific CD8+ T lymphocytes in rhesus macaques | Q36087816 | ||
| Nonhuman primate models of intrauterine cytomegalovirus infection | Q36359753 | ||
| Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects | Q36402863 | ||
| Characterization of the rhesus cytomegalovirus US28 locus | Q36525364 | ||
| Analysis of the rhesus cytomegalovirus immediate-early gene promoter | Q36771392 | ||
| Cytotoxic T-lymphocyte responses to cytomegalovirus in normal and simian immunodeficiency virus-infected rhesus macaques | Q36829690 | ||
| Reevaluation of human cytomegalovirus coding potential. | Q37089601 | ||
| A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism. | Q37596973 | ||
| Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. | Q37879797 | ||
| Congenital and perinatal cytomegalovirus infections | Q37897929 | ||
| The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections | Q38063596 | ||
| Cloning and characterization of rhesus cytomegalovirus glycoprotein B. | Q38343893 | ||
| Pathogenesis of experimental rhesus cytomegalovirus infection. | Q39596653 | ||
| Decreased frequency of cytomegalovirus (CMV)-specific CD4+ T lymphocytes in simian immunodeficiency virus-infected rhesus macaques: inverse relationship with CMV viremia | Q39683300 | ||
| Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. | Q39872953 | ||
| Analysis of the complete DNA sequence of murine cytomegalovirus | Q39877356 | ||
| Replication of rhesus cytomegalovirus in life-expanded rhesus fibroblasts expressing human telomerase | Q40721705 | ||
| Characterization of rhesus cytomegalovirus genes associated with anti-viral susceptibility | Q40870919 | ||
| Primate cytomegaloviruses encode and express an IL-10-like protein | Q41723248 | ||
| Rhesus cytomegalovirus particles prevent activation of interferon regulatory factor 3. | Q41885111 | ||
| Neuropathogenesis induced by rhesus cytomegalovirus in fetal rhesus monkeys (Macaca mulatta). | Q41926665 | ||
| Nucleotide sequence and molecular analysis of the rhesus cytomegalovirus immediate-early gene and the UL121-117 open reading frames | Q42625661 | ||
| Identification of the gene coding for rhesus cytomegalovirus glycoprotein B and immunological analysis of the protein | Q42662287 | ||
| Differential function and expression of the viral inhibitor of caspase 8-induced apoptosis (vICA) and the viral mitochondria-localized inhibitor of apoptosis (vMIA) cell death suppressors conserved in primate and rodent cytomegaloviruses | Q42833665 | ||
| Genomic sequence of rhesus cytomegalovirus 180.92: insights into the coding potential of rhesus cytomegalovirus | Q43085610 | ||
| Immunohistochemical studies of productive rhesus cytomegalovirus infection in rhesus monkeys (Macaca mulatta) infected with simian immunodeficiency virus | Q43705445 | ||
| Persistent shedding of cytomegalovirus in the urine of healthy Rhesus monkeys | Q43771937 | ||
| Anti-CD40 therapy extends renal allograft survival in rhesus macaques | Q44190483 | ||
| Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection | Q45420228 | ||
| Differential detection of B virus and rhesus cytomegalovirus in rhesus macaques | Q45729510 | ||
| Plasma and CSF pharmacokinetics of ganciclovir in nonhuman primates | Q45857217 | ||
| Multicolor flow cytometric analysis in SIV-infected rhesus macaque | Q45880085 | ||
| Development and homeostasis of T cell memory in rhesus macaque | Q45882091 | ||
| Antibody responses to rhesus cytomegalovirus glycoprotein B in naturally infected rhesus macaques. | Q45988570 | ||
| Seroepidemiologic studies of cytomegalovirus infection in a breeding population of rhesus macaques | Q46085085 | ||
| Epidemic of acquired immunodeficiency in rhesus monkeys | Q46090781 | ||
| Characterization and immunological analysis of the rhesus cytomegalovirus homologue (Rh112) of the human cytomegalovirus UL83 lower matrix phosphoprotein (pp65). | Q46549192 | ||
| Experimental congenital disease with simian cytomegalovirus in rhesus monkeys | Q46979650 | ||
| Identification of essential and non-essential genes of the guinea pig cytomegalovirus (GPCMV) genome via transposome mutagenesis of an infectious BAC clone | Q47891874 | ||
| The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome | Q48264323 | ||
| Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity. | Q50465721 | ||
| Expression of CD8alpha identifies a distinct subset of effector memory CD4+ T lymphocytes. | Q51981076 | ||
| Gastrointestinal pathology in rhesus monkeys with experimental SIV infection | Q64382006 | ||
| Ocular manifestation of simian immunodeficiency syndrome (SAIDS) | Q68493603 | ||
| Natural and experimental simian cytomegalovirus infections at a primate center | Q70149861 | ||
| Primate cytomegalovirus US12 gene family: a distinct and diverse clade of seven-transmembrane proteins | Q80098102 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 109-115 | |
| P577 | publication date | 2008-01-11 | |
| P1433 | published in | Medical Microbiology and Immunology | Q15760239 |
| P1476 | title | Rhesus CMV: an emerging animal model for human CMV. | |
| P478 | volume | 197 |
| Q91675842 | A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection |
| Q34625160 | A non-human primate model for analysis of safety, persistence, and function of adoptively transferred T cells |
| Q26767476 | Animal Models for HIV Cure Research |
| Q28389500 | Animal models of intellectual disability: towards a translational approach |
| Q36240617 | Antagonism of the protein kinase R pathway by the guinea pig cytomegalovirus US22-family gene gp145. |
| Q47269191 | Antagonism of the protein kinase R pathway in human cells by rhesus cytomegalovirus |
| Q64450813 | CD8 T-Cell Immunotherapy of Cytomegalovirus Disease in the Murine Model |
| Q48273032 | CMV and natural killer cells: shaping the response to vaccination. |
| Q38257496 | CMV-encoded Fcγ receptors: modulators at the interface of innate and adaptive immunity |
| Q42267802 | Characterization of the guinea pig CMV gH/gL/GP129/GP131/GP133 complex in infection and spread |
| Q40067378 | Chemokines encoded by herpesviruses |
| Q36685041 | Coding potential of UL/b' from the initial source of rhesus cytomegalovirus Strain 68-1. |
| Q60046851 | Cytokine-Mediated Tissue Injury in Non-human Primate Models of Viral Infections |
| Q43409130 | Cytomegaloviral hypophysitis in a simian immunodeficiency virus-infected rhesus macaque (Macacca mulatta). |
| Q40145257 | Cytomegalovirus UL128 homolog mutants that form a pentameric complex produce virus with impaired epithelial and trophoblast cell tropism and altered pathogenicity in the guinea pig. |
| Q27000998 | Cytomegalovirus antivirals and development of improved animal models |
| Q37728492 | Cytomegalovirus pp65 limits dissemination but is dispensable for persistence. |
| Q35150896 | Cytomegalovirus-specific T cell immunity is maintained in immunosenescent rhesus macaques |
| Q59359836 | Cytomegalovirus: Shape-Shifting the Immune System |
| Q47235213 | Cytomegaloviruses in a Community of Wild Nonhuman Primates in Taï National Park, Côte D'Ivoire |
| Q34994012 | Demystifying animal models of adverse pregnancy outcomes: touching bench and bedside |
| Q37574334 | Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next? |
| Q37287080 | Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge |
| Q38272313 | Epigenetic regulation of human cytomegalovirus latency: an update |
| Q37373301 | Extraction and characterization of the rhesus macaque T-cell receptor beta-chain genes |
| Q34362454 | Generation of a specific-pathogen-free baboon colony. |
| Q64062672 | HLA-E: exploiting pathogen-host interactions for vaccine development |
| Q35099535 | How the virus outsmarts the host: function and structure of cytomegalovirus MHC-I-like molecules in the evasion of natural killer cell surveillance |
| Q33618817 | Human cytomegalovirus Fcγ binding proteins gp34 and gp68 antagonize Fcγ receptors I, II and III |
| Q37807749 | Human cytomegalovirus immunity and immune evasion |
| Q35899274 | Human cytomegalovirus persistence |
| Q93380481 | Identification and Functional Characterization of a Novel Fc Gamma-Binding Glycoprotein in Rhesus Cytomegalovirus |
| Q90062898 | Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease |
| Q37798997 | In vivo impact of cytomegalovirus evasion of CD8 T-cell immunity: facts and thoughts based on murine models. |
| Q47563927 | Is a Human CD8 T-Cell Vaccine Possible, and if So, What Would It Take? Could a CD8+ T-Cell Vaccine Prevent Persistent HIV Infection? |
| Q43449637 | Isolation and characterization of cynomolgus macaque (Macaca fascicularis) cytomegalovirus (CyCMV). |
| Q57092575 | Long-term safety outcome of systemic immunosuppression in pig-to-nonhuman primate corneal xenotransplantation |
| Q91013920 | Modulation of innate and adaptive immunity by cytomegaloviruses |
| Q60913862 | Mouse Model of Cytomegalovirus Disease and Immunotherapy in the Immunocompromised Host: Predictions for Medical Translation that Survived the "Test of Time" |
| Q37677563 | Mouse models in bone marrow transplantation and adoptive cellular therapy |
| Q38041963 | Murine cytomegalovirus immune evasion proteins operative in the MHC class I pathway of antigen processing and presentation: state of knowledge, revisions, and questions |
| Q57794125 | Natural history of postnatal rhesus cytomegalovirus shedding by dams and acquisition by infant rhesus monkeys |
| Q47167247 | Neutralization of Human Cytomegalovirus Entry into Fibroblasts and Epithelial Cells |
| Q36011269 | New paradigms for HIV/AIDS vaccine development |
| Q37387045 | Oncomodulation by human cytomegalovirus: evidence becomes stronger. |
| Q34145201 | Oncomodulation by human cytomegalovirus: novel clinical findings open new roads |
| Q40897276 | Potential Contribution of Cytomegalovirus Infection to Prenatal and Early Neonatal Mortality of Monkeys in the Adler Breeding Center |
| Q36154996 | Reevaluation of the coding potential and proteomic analysis of the BAC-derived rhesus cytomegalovirus strain 68-1. |
| Q34495529 | Reverse genetics modification of cytomegalovirus antigenicity and immunogenicity by CD8 T-cell epitope deletion and insertion |
| Q37350364 | Rhesus cytomegalovirus a nonhuman primate model for the study of human cytomegalovirus |
| Q33888548 | Simian herpesviruses and their risk to humans |
| Q37827868 | Sources and signals regulating type I interferon production: lessons learned from cytomegalovirus |
| Q39898534 | T cells engineered with a cytomegalovirus-specific chimeric immunoreceptor. |
| Q35622061 | The interplay between immune maturation, age, chronic viral infection and environment |
Search more.